Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 10/20 | 0.42 |
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26634462 | 0.93 | PDK2 (0.45) | PDK2BCHEACHENOX1CYP1A2 | |
| SCHEMBL23382843 | 0.92 | PDK2 (0.40) | PDK2BCHEACHENOX1CYP1A2 | |
| SCHEMBL24723595 | 0.91 | PDK2 (0.44) | PDK2BCHEACHENOX1CYP1A2 | |
| SCHEMBL23372411 | 0.89 | PDK2 (0.49) | PDK2BCHEACHENOX1CYP1A2 | |
| SCHEMBL23372416 | 0.86 | PDK2 (0.51) | PDK2BCHEACHENOX1HPGD | |
| SCHEMBL23382846 | 0.86 | PDK2 (0.46) | PDK2BCHEACHENOX1CYP1A2 | |
| SCHEMBL23372318 | 0.86 | PDK2 (0.44) | PDK2BCHEACHENOX1CYP1A2 | |
| SCHEMBL23383364 | 0.84 | PDK2 (0.48) | PDK2BCHEACHENOX1PGR | |
| SCHEMBL29292807 | 0.84 | PDK2 (0.37) | PDK2CYP1A2PGR | |
| SCHEMBL24027782 | 0.83 | PDK2 (0.39) | PDK2BCHEACHENOX1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339923-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-26 | — | — | US | disclosed |
| US-20230339923-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339923-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | NFE2L2, ESR1, OR51E2 | PDK2 1979/4885BCHE 1785/4885ACHE 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.